What Parameters And Treatment Protocols Are Required When Targeting Vascular Lesions With Vascular Laser Systems? Choose The Right Wavelength And Settings

Vascular laser treatment requires matching wavelength, pulse duration, spot size, fluence, and cooling to the lesion’s vessel diameter, depth, and location. Shorter wavelengths such as 532–600 nm are generally suited to superficial telangiectasias, while longer wavelengths—especially 1064 nm Nd:YAG—are preferred for deeper or larger vessels. A typical course involves three to four treatments spaced approximately three to four weeks apart, but settings must be individualized by a qualified clinician.

The correct protocol is lesion-specific, not device-specific. Select the wavelength according to vessel depth and hemoglobin absorption, then adjust pulse duration, spot size, fluence, and cooling to produce vessel blanching or vasospasm while avoiding epidermal injury.

How to Select the Treatment Parameters

Wavelength: match penetration depth

Wavelength determines how strongly the laser is absorbed and how deeply it penetrates. Superficial red vessels respond well to visible wavelengths, whereas deeper or larger vessels generally require near-infrared systems.

532 nm KTP: fine, superficial telangiectasias.
585–600 nm pulsed dye or yellow-light systems: superficial vascular lesions and proliferating vascular lesions.
755 nm Alexandrite: deeper or more resistant vascular lesions.
800–940 nm diode systems: selected superficial-to-deep vascular targets.
1064 nm Nd:YAG: deeper reticular veins, larger vessels, and lesions inadequately responsive to visible wavelengths.

Longer wavelengths may improve treatment of deeper vessels, but they also require careful control of fluence and epidermal protection.

Pulse duration: match vessel diameter

Pulse duration should approximate the target vessel’s thermal relaxation time. In practical terms, smaller vessels require shorter pulses, while larger vessels generally need longer pulses to heat the vessel uniformly without excessive surface injury.

Common ranges reported for different systems include:

Superficial telangiectasias: approximately 1–10 ms, depending on vessel size and device.
Larger or deeper vessels: approximately 20–100 ms with long-pulsed Nd:YAG systems.
Vessels greater than 2 mm: protocols may use approximately 50–100 ms.
Smaller telangiectasias treated with Nd:YAG: approximately 20–50 ms.

Pulse durations must not be transferred directly between platforms. A nominal 10 ms pulse on one device may not deliver the same temporal or spatial energy profile as a 10 ms pulse on another.

Spot size: balance depth and precision

Spot size affects scattering, penetration depth, treatment speed, and the fluence required. Larger spots generally penetrate more effectively and provide more uniform coverage, while smaller spots can be useful for precise treatment of small or sharply defined vessels.

For long-pulsed Nd:YAG treatment, the spot is commonly selected to be approximately 25–50% wider than the target vessel. Reported examples include:

5–6 mm spot: approximately 80–120 J/cm².
3–4 mm spot: approximately 150–200 J/cm².
1–2 mm spot: approximately 350–500 J/cm².

These values are not universal prescriptions. Fluence depends on wavelength, pulse duration, skin type, cooling, device design, and treatment site; higher fluence is not automatically better.

Fluence: deliver enough energy, but avoid injury

Fluence is the energy delivered per unit area and determines the amount of thermal injury created in the vessel. It should be increased or decreased according to the observed clinical response and the safety of the surrounding skin.

For some superficial proliferating vascular lesions, protocols using a 595 nm wavelength, 9–10 mm spot, 1.5–40 ms pulse duration, and approximately 6.0–6.5 J/cm² with active cooling have been reported. These settings are device- and indication-specific and should not be generalized to Nd:YAG, KTP, or diode systems.

Cooling: protect the epidermis

Cooling is an essential part of vascular laser treatment, particularly when using higher fluence or longer-wavelength systems. Contact cooling, cryogen spray, and forced air cooling can reduce epidermal heating and improve patient comfort.

Cooling should be coordinated with the laser pulse. Inadequate cooling increases the risk of blistering, epidermal necrosis, dyspigmentation, and scarring; excessive or poorly timed cooling may reduce the intended thermal effect.

How Protocols Change by Lesion Type

Fine superficial telangiectasias

Fine superficial vessels are typically approached with high-absorption visible wavelengths, such as 532 nm KTP or 585–600 nm pulsed dye systems. Reported pulse durations range from approximately 0.45–1.5 ms for pulsed dye systems and 1–100 ms for KTP, depending on vessel caliber and device capability.

The endpoint is usually vessel blanching, transient purpura, or vasospasm rather than aggressive tissue destruction. Some superficial protocols describe two to four consecutive pulses, but pulse stacking should only be used when specifically supported by the device protocol and clinical indication.

Spider hemangiomas

Spider hemangiomas contain a central feeder vessel and radiating superficial vessels. Treatment often requires attention to the central feeder, using a vascular laser or, in selected cases, a 980 nm diode system.

A reported diode example uses approximately 40 ms and 13–15 J/cm², but these values are not interchangeable with other devices. The clinician should assess the response of the feeder and peripheral vessels separately rather than repeatedly treating the same point without observing the tissue endpoint.

Angiokeratomas

Angiokeratomas may have a more keratotic or raised surface and can require different treatment strategies from flat telangiectasias. Long-pulsed Nd:YAG or pulsed CO₂ systems may be used, with some protocols describing defocused CO₂ treatment at approximately 0.20 seconds and 1–2 W.

Because these lesions can bleed and may resemble other pigmented or vascular growths, diagnosis should be established before treatment. Atypical, changing, ulcerated, or solitary lesions warrant appropriate medical evaluation.

Deeper reticular veins and larger vessels

Deeper or larger vessels generally require greater penetration, making 755 nm Alexandrite, diode, or 1064 nm Nd:YAG systems more appropriate than short visible wavelengths.

For long-pulsed Nd:YAG treatment of vessels approximately 0.3–6 mm in diameter, pulse durations of 20–50 ms may be used for smaller vessels and 50–100 ms for larger veins. The spot should generally exceed vessel width, and treatment must include continuous cooling.

Port-wine stains and resistant lesions

Some port-wine stains respond incompletely to conventional single-wavelength treatment, particularly when vessels are large, deep, or ectatic. In these cases, clinicians may consider longer-wavelength systems such as 755 nm Alexandrite or 1064 nm Nd:YAG, sometimes with dynamic cooling and carefully adjusted fluence.

Longer wavelengths may reach deeper dermal vascular networks, but they also carry greater risk in heavily pigmented skin if epidermal protection and parameter selection are inadequate.

The Required Treatment Protocol

Establish the diagnosis and lesion profile

Before selecting settings, document:

Lesion type and diagnosis
Vessel color, diameter, and depth
Anatomic location
Skin phototype and degree of tanning
Prior laser, IPL, or sclerotherapy
History of abnormal scarring, pigmentary change, or photosensitivity

Lesions that are atypical, rapidly changing, ulcerated, painful, or diagnostically uncertain should not be treated solely as cosmetic vascular lesions.

Perform a test area when appropriate

A test spot is particularly important when treating darker skin types, recently tanned skin, deeper lesions, or unfamiliar device–tissue combinations. The response should be assessed for both the intended vascular endpoint and delayed epidermal or pigmentary complications.

Use controlled single-pass treatment

Avoid indiscriminate overlap and repeated passes. With long-pulsed Nd:YAG systems, pulse stacking and excessive spot overlap should generally be avoided because accumulated heat can cause epidermal necrosis, scarring, and prolonged pigmentary change.

Where a protocol specifically supports stacking—such as selected superficial telangiectasia techniques—it must be performed conservatively and only with appropriate cooling and real-time tissue assessment.

Treat to a clinical endpoint

Useful endpoints may include:

Vessel blanching
Transient vasospasm
Appropriate purpura, particularly with some pulsed dye laser protocols
Immediate vessel darkening or coagulation, depending on the system

The endpoint should not be uncontrolled whitening, blistering, charring, or epidermal disruption. These findings indicate excessive thermal injury rather than improved efficacy.

Schedule staged treatments

Vascular lesions commonly require a series rather than one aggressive session. The primary protocol describes three to four treatments at intervals of three to four weeks, with the interval adjusted according to lesion response, inflammation, clearance, and the specific device.

Deeper or resistant lesions may require additional sessions or a change in wavelength rather than simply increasing fluence.

Understanding the Trade-offs

More penetration can increase risk

Longer wavelengths improve access to deeper vessels but may deliver substantial heat to surrounding tissue. This is why cooling, conservative escalation, and careful endpoint monitoring are particularly important with 755 nm and 1064 nm systems.

Higher fluence is not a substitute for correct matching

If a vessel does not respond, the problem may be wavelength, pulse duration, spot size, or insufficient penetration—not simply inadequate fluence. Increasing energy without correcting the mismatch can cause burns without improving clearance.

Pulse stacking is not universally appropriate

Some superficial protocols describe stacking two to four pulses, while long-pulsed Nd:YAG protocols caution against stacking and overlap. These recommendations are not contradictory when understood as device- and indication-specific; stacking must never be treated as a general rule.

Treatment response may plateau

Visible wavelengths may clear superficial components while leaving deeper vessels untreated. For recalcitrant lesions, changing wavelength or treatment strategy may be safer and more effective than repeatedly intensifying the same protocol.

Pigmentary complications remain possible

Post-inflammatory hyperpigmentation, hypopigmentation, blistering, and scarring can occur, especially with excessive fluence, inadequate cooling, overlapping pulses, recent tanning, or treatment of higher-risk skin types. Informed consent and appropriate follow-up are essential.

How to Apply This to a Treatment Plan

The final settings must come from the device manufacturer’s instructions and a trained clinician’s assessment of the individual lesion.

If your primary focus is superficial telangiectasias: Begin with a hemoglobin-absorbing visible wavelength, short-to-moderate pulse duration, conservative fluence, appropriate spot size, and effective epidermal cooling.
If your primary focus is deeper or larger vessels: Consider a longer-wavelength system such as 1064 nm Nd:YAG, using longer pulses, a spot wider than the vessel, continuous cooling, and no uncontrolled overlap or stacking.
If your primary focus is a resistant vascular lesion: Reassess vessel depth and diameter before increasing energy; a different wavelength or staged protocol may be more appropriate.
If your primary focus is treatment safety: Use a test area when indicated, treat to a controlled vascular endpoint, document settings, and stop if epidermal injury appears.
If your primary focus is durable clearance: Plan a staged course—often three to four sessions separated by approximately three to four weeks—rather than attempting to clear the lesion in one aggressive treatment.

Successful vascular laser treatment comes from matching the laser’s thermal delivery to the vessel while protecting the skin that surrounds it.

Summary Table:

Parameter	Key Considerations	Typical Settings
Wavelength	Match to vessel depth and hemoglobin absorption	532 nm for superficial; 1064 nm for deep/large vessels
Pulse Duration	Match to vessel diameter (thermal relaxation time)	1–10 ms for small; 20–100 ms for larger vessels
Spot Size	Larger for depth and coverage; smaller for precision	1–6 mm depending on vessel size
Fluence	Deliver enough energy without epidermal injury	6–500 J/cm² depending on spot and device
Cooling	Protect epidermis and improve comfort	Contact, cryogen, or forced air cooling
Treatment Course	Often multiple sessions spaced 3–4 weeks apart	3–4 treatments typical

At BELIS, we provide professional-grade vascular laser systems designed for clinics and premium salons. Our advanced devices, including Nd:YAG, diode, and Alexandrite lasers, feature precise parameters and integrated cooling for safe, effective vascular lesion treatment. Whether you're targeting superficial telangiectasias or deeper reticular veins, our systems can be tailored to your practice needs. Contact our experts today to find the ideal vascular laser solution for your clients. Get in touch with us!